Review

How Do Satellite Glial Cells Control Chronic Pain?

Xiaojuan Liu , Travis Goettemoeller , Temugin Berta
Department of Pathogen Biology, Medical College, Nantong University, Nantong, China, Pain Research Center, Department of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH, USA
J Anesth Perioper Med 2018; 5(6): 306- 315 . Published on Nov 28, 2018 . doi:10.24015/JAPM.2018.0114
Abstract
Article
Author & Article info
PDF

Abstract

Aim of review: Pain afflicts more than 1.5 billion people worldwide, with hundreds of millions suffering from unrelieved chronic pain. Accumulating evidence suggests that satellite glial cells (SGCs) play active roles in the pathogenesis of pain. We review how SGCs interact with nociceptive neurons by secreting neuroactive signaling molecules that modulate pain, which may offer new therapeutic strategies for the prevention and treatment of chronic pain.
 
Methods: According to the available literature, we first described the morphology and physiology of SGCs in sensory ganglia and then provided an overview of the signaling molecules by which SGCs contribute to the modulation of the neuronal activity in various animal models of acute and chronic pain. Finally, we addressed some outstanding questions about SGCs that remain to be answered in future research and clinical applications.
 
Recent findings: Accumulating evidence has implicated structural and biochemical changes in SGCs in chronic pain: gliosis (i.e. proliferation), increase in expression of glial fibrillary acidic protein (a marker for their activation), modulation of glutamate transporters and ion channels, increases in purinergic and cytokine signaling, as well as aberrant connectivity between neighboring SGCs and sensory neurons. These changes alter the activity of sensory neurons and contribute to the development and maintenance of chronic pain. Remarkably, SGCs also participate in acute pain, and acute opioid treatment activates SGCs to mask opioid analgesia.
 
Summary: SGCs are now recognized players in the pathogenesis of chronic pain through the secretion of neuroactive signaling molecules and controls of nociceptive neurons. Given the inadequate treatment of chronic pain by the current “neurocentric” drugs, these recently recognized roles of SGCs and their neuroactive signaling molecules are exciting as they predict novel approaches for effective control of chronic pain. (Funded by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS), and the University of Cincinnati.) 
 
 
 
 
Citation: Xiaojuan Liu, Travis Goettemoeller, Temugin Berta. How Do Satellite Glial Cells Control Chronic Pain? J Anesth Perioper Med 2018;5:306-315. doi: 10.24015/JAPM.2018.0114
 
This is an open-access article, published by Evidence Based Communications (EBC). This work is licensed under the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium or format for any lawful purpose. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 

Copyright © 2014-2018 | Evidence Based Communications (EBC)   All Rights Reserved.
Privacy Policy | Terms of Use | NIH Public Access Policy
ISSN: 2306-773X (Print) and 2520-3002 (Online)Submit a Manuscript | EBC and EBC Journals

The content on this site is intended for health professionals.
Loading